The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.

Attorney General Getner Drummond issued a warning to those who have used the genetic testing company 23andMe. The company has now filed for bankruptcy, and Drummond said in a statement that it will likely sell its corporate assets, a move that could include stored genetic data submitted by users.

Oklahoma Attorney General Gentner Drummond issued a consumer alert for concerned 23andMe customers after the genetic testing company filed for bankruptcy protection last month.

The bankruptcy follows a tumultuous 18 months for 23andMe, marked by declining sales ... grievances unrelated to the cyberattack, such as issues with DNA test results or the company's telehealth ...